Arcadia Biosciences (RKDA) Current Assets (2014 - 2025)

Arcadia Biosciences' Current Assets history runs 12 years deep, the most recent figure standing at $6.4 million for Q4 2025.

• Quarterly Current Assets fell 31.23% year-over-year to $6.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.4 million (down 31.23% YoY) and the FY2025 annual result came in at $6.4 million, down 31.23% from the prior year.
• Current Assets was $6.4 million for Q4 2025 at Arcadia Biosciences, down from $8.4 million in the prior quarter.
• Across five years, Current Assets topped out at $56.6 million in Q1 2021 and bottomed at $6.4 million in Q4 2025.
• A 5-year average of $23.2 million and a median of $21.7 million in 2023 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2021 — Current Assets jumped 138.29% — and 2024, when it sank 57.21%.
• Arcadia Biosciences' Current Assets stood at $35.4 million in 2021, then dropped by 28.23% to $25.4 million in 2022, then sank by 41.05% to $15.0 million in 2023, then sank by 38.27% to $9.2 million in 2024, then sank by 31.23% to $6.4 million in 2025.
• Business Quant data shows RKDA's Current Assets at $6.4 million in Q4 2025, $8.4 million in Q3 2025, and $7.6 million in Q2 2025.